Itraconazole Neon Healthcare

Itraconazole, the active ingredient in Itraconazole Neon Healthcare, is an azole antifungal presented as an intravenous solution for intravenous use. It treats systemic fungal infections such as invasive aspergillosis, blastomycosis, histoplasmosis, coccidioidomycosis, sporotrichosis and dermatophytosis in adult patients.

GNH USA supplies Itraconazole Neon Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Itraconazole is an azole antifungal used to treat systemic mycoses and deep tissue fungal infections.

- Invasive aspergillosis: eradicates the pathogen and improves survival. - Blastomycosis: clears pulmonary and disseminated infection. - Histoplasmosis: resolves chronic and disseminated disease. - Coccidioidomycosis: treats severe pulmonary and disseminated forms. - Sporotrichosis: eliminates cutaneous and disseminated infection. - Dermatophytosis: resolves extensive skin fungal infections.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea - Headache - Elevated liver enzymes - Rash

Serious or Rare Side Effects: - Hepatotoxicity - Severe allergic reactions including anaphylaxis - Cardiac arrhythmias - Visual disturbances - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Neutropenia

Use of Itraconazole requires careful monitoring and specific safety measures.

- Monitor liver function: obtain baseline and periodic liver‑function tests. - Assess cardiac status: avoid in patients with known ventricular dysfunction. - Review concomitant medications: avoid strong CYP3A4 inhibitors. - Adjust therapy in renal impairment: consider dose modification if needed. - Store at ambient temperature: keep in original container, protect from light and moisture.

Itraconazole has several clinically important drug interactions.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) - Rifampin (potent enzyme inducer) - St. John’s wort (herbal CYP3A4 inducer)

Moderate Interactions (Monitor Closely): - Calcium channel blockers (e.g., verapamil) - Oral contraceptives (reduced efficacy) - Warfarin (altered anticoagulant effect)